logo
logo

Rapha Capital Management Participates in Series D Financing for Poseida Therapeutics

Jun 25, 2020•about 5 years ago

Round Type

series d

Miami

Description

 Rapha Capital Management, LLC (https://raphacap.com), an investment management firm located in Miami, Florida, through Rapha Capital Investment XI, LLC ("RCI XI") (an entity managed by Rapha Capital), participated in Poseida Therapeutics Inc.'s Series D financing, led by funds advised by Fidelity Management Research Company, LLC.  RCI XI invested $2 million in this $110 million financing round, adding to its previous investments, through Rapha Capital Investment III, LLC (an entity managed by Rapha Capital), of $1 million in Poseida's Series A-1 financing in 2017 and $2 million in Poseida's Series C financing in 2019 via Rapha Capital Investment VI, LLC.

Company Information

Company

Rapha Capital Management, Llc

Location

Miami, Florida, United States

About

–  Rapha Capital Management, LLC is an investment management firm located in Miami, Florida, focusing on strategic investments in early stage, non-public biotechnology companies.  Rapha Capital was founded by its President, Kevin Slawin, MD, a successful and experienced oncologic and robotic surgeon, biotech consultant, investor, and founder focusing on technologies in oncology, T cells and immunotherapy, as well as other breakthrough healthcare technologies.  He is the founder of Bellicum Pharmaceuticals, Inc.  He is co-Inventor of the FDA,-approved "prostate health index (phi)" test licensed and marketed by Beckman Coulter and utilized around the world.  He has published extensively in top medical and scientific journals including the Journal of the American Medical Association (JAMA), Journal of the National Cancer Institute (JNCI), and the New England Journal of Medicine (NEJM).  He has also been routinely listed in America's Top Doctors for Cancer (Castle Connolly Medical) and The Best Doctors in America (Woodward/White).  In 2003, he was awarded the F. Brantley Scott, Jr., Award for Innovation and Creativity in Urology.

FundzWatch™ Score

70
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood